Learn more about participating in or partnering with us to enroll a patient in our clinical trials at the NIH Clinical Center in Bethesda, MD. Explore whether one may be right for you, a patient, or a loved one.
HIV and AIDS Malignancy Branch Clinical Research Team
Our highly trained physicians develop and conduct a wide range of clinical trials in a quest to develop the medicines of tomorrow.
The HIV and AIDS Malignancy Branch (HAMB), which was founded in October 1996, conducts laboratory and clinical research in AIDS-related malignancies, HIV disease, viral-induced tumors, and related diseases. The mission of HAMB is to understand the pathogenesis of these diseases and to develop novel therapies for them based on this understanding. HAMB research is translational and is comprised of an integrated laboratory and clinical effort. Laboratory research is focused on developing and studying new therapies for HIV infection, on the tumors that cause HIV-associated malignancies, and on developing novel therapies for HIV-associated cancers. Clinical research is currently directed towards AIDS-related malignancies.
Our highly trained physicians develop and conduct a wide range of clinical trials in a quest to develop the medicines of tomorrow for patients with cancer, HIV or immunodeficiency disorders. All of our trials take place at the NIH Clinical Center in Bethesda, MD, the world's largest research hospital, and through telehealth. Once you are enrolled in a clinical trial at the Clinical Center, medical care is free.